Abstract
Background
There is increasing demand for minimally invasive treatments for small breast cancer mainly because of the desire for better cosmetic results. Although radiofrequency ablation (RFA) is an attractive approach as a local control method for small breast cancer, the problems of histological effectiveness and safety management remain.
Methods
A total of 29 patients including one patient with bilateral breast cancer were enrolled in this study. The mean tumor size of 30 breasts was 12.8 mm (range 5–19 mm). Under general anesthesia, RFA was performed with a Cool-tip RF system (Valleylab, Boulder, CO, USA) after sentinel lymph node biopsy. Postoperative evaluation with magnetic resonance imaging (MRI) and vacuum-assisted core needle biopsy was done 3–4 weeks after RFA before radiotherapy. Ablated tumors were evaluated with hematoxylin–eosin (H&E) and nicotinamide adenine dinucleotide (NADH)-diaphorase staining. If needed, adjuvant chemo and/or endocrine therapy was performed.
Results
All patients except one completed one session of RFA. The mean temperature near the center of the tumors was 89.6°C (range 78–100°C). Postoperative MRI showed the ablated zone clearly in all patients. MRI revealed no hypervascularity of the tumors in the ablated zone. Evaluation with H&E staining of the tumors showed remarkable degenerative changes in only three patients. NADH-diaphorase staining showed no viable tumor tissue in 24 patients out of 26 examined. Three patients received small diameter grade 3 skin burns, two on the outside of the thigh from the grounding pad and one on the breast skin. One patient had a breast lesion like a chronic granulomatous mastitis resulting from overreaction of the ablated zone.
Conclusions
RFA therapy appeared relevant and applicable for patients with small breast cancer. Because small skin burns were observed as adverse events, close attention should be paid in the course of the RFA procedure.
Similar content being viewed by others
Abbreviations
- RFA:
-
Radiofrequency ablation
- MRI:
-
Magnetic resonance imaging
- MDCT:
-
Multi-detector computed tomography
- H&E:
-
Hematoxylin–eosin
- NADH:
-
Nicotinamide adenine dinucleotide
References
Jeffrey SS, Birdwell RL, Ikeda DM, Daniel BL, Nowels KW, Dirbas FM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg. 1999;134:1064–8.
Izzo F, Thomas R, Delrio P, Rinaldo M, Vallone P, DeChiara A, et al. Radiofrequency ablation in patients with primary breast carcinoma. A pilot study in 26 patients. Cancer. 2001;92:2036–44.
Mirza AN, Fornage BD, Sneige N, Kuerer HM, Newman LA, Ames FC, et al. Radiofrequency ablation of solid tumors. Cancer J. 2001;7:95–102.
Singletary SE. Feasibility of radiofrequency ablation for primary breast cancer. Breast Cancer. 2003;10:4–9.
Noguchi M, Earashi M, Fujii H, Yokoyama K, Harada K, Tsuneyama K. Radiofrequency ablation of small breast cancer followed by surgical resection. J Surg Oncol. 2006;93:120–8.
Imoto S, Wada N, Sakemura N, Hasebe T, Murata Y. Feasibility study on radiofrequency ablation followed by partial mastectomy for stage I breast cancer patients. Breast. 2009;18:130–4.
Elliott RI, Rice PB, Suits JA, Ostrowe AJ, Head JF. Radiofrequency ablation of a stereotactically localized nonpalpable breast carcinoma. Am Surg. 2002;68:1–5.
Burak WE Jr, Agnese DM, Povoski SP, Yanssens TL, Bloom KJ, Wakely PE, et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer. 2003;98:1369–76.
Hayashi AH, Silver SF, van der Westhuizen NG, Donald JC, Parker C, Fraser S, et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg. 2003;185:429–35.
Susini T, Nori J, Olivieri S, Livi L, Bianchi S, Mangialavori G, et al. Radiofrequency ablation for minimally invasive treatment of breast carcinoma, a pilot study in elderly inoperable patients. Gynecol Oncol. 2007;104(2):304–10.
Marcy PY, Magné N, Castadot P, Bailet C, Namer M. Ultrasound-guided percutaneous radiofrequency ablation in elderly breast cancer patients: preliminary institutional experience. Br J Radiol. 2007;80:267–73.
Noguchi M. Radiofrequency ablation treatment for breast cancer to meet the next challenge: how to treat primary breast tumor without surgery. Breast Cancer. 2003;10:203–5.
Earashi M, Noguchi M, Motoyoshi A, Fujii H. Radiofrequency ablation therapy for small breast cancer followed by immediate surgical resection or delayed mammotome excision. Breast Cancer. 2007;14:39–47.
Oura S, Tamaki T, Hirai I, Yoshimasu T, Ohta F, Nakamura R, et al. Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size. Breast Cancer. 2007;14:48–54.
Nagashima T, Sakakibara M, Sangai T, Kazama T, Fujimoto H, Miyazaki M. Surrounding rim formation and reduction in size after radiofrequency ablation for primary breast cancer. Jpn J Radial. 2009;27:197–204.
Fornage BD, Sneige N, Ross MI, Mirza AN, Kuerer HM, Edeiken BS, et al. Small breast cancer treated with US-guided radiofrequency ablation. Radiology. 2004;231:215–24.
Manenti G, Bolacchi F, Perretta T, Cossu E, Pistolese CA, Buonomo OC, et al. Small breast cancers: in vivo percutaneous US-guided radiofrequency ablation with dedicated cool-tip radiofrequency system. Radiology. 2009;251:339–46.
Diesing D, Axt-Fliedner R, Hornung D, Weiss JM, Diedrich K, Friedrich M. Granulomatous mastitis. Arch Gynecol Obstet. 2004;269:233–6.
Bässler R. Mastitis. Classification, histopathology and clinical aspects. Pathologe. 1997;18:27–36.
Head JF, Elliott RL. Stereotactic radiofrequency ablation: a minimally invasive technique for nonpalpable breast cancer in postmenopausal patients. Cancer Epidemiol. 2009;33:300–5.
Acknowledgments
This study was supported in part by a grant from Clinical Research for the Development of Preventive Medicine and New Therapeutics of Health and Labor Science Research from the Ministry of Health, Labor and Welfare, Japan.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yamamoto, N., Fujimoto, H., Nakamura, R. et al. Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety management. Breast Cancer 18, 3–9 (2011). https://doi.org/10.1007/s12282-010-0197-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-010-0197-6